Khamboon Thidarat, Pakanta Intira
Department of Nursing, Faculty of Nursing, Naresuan University, Phitsanulok, Thailand.
Asia Pac J Oncol Nurs. 2021 Mar 9;8(3):267-275. doi: 10.4103/2347-5625.311003. eCollection 2021 May-Jun.
Patients with lung cancer can experience various distressing symptoms. The present study aims to use symptom cluster management intervention based on symptom management theory to moderate the severity of symptom clusters, including fatigue, loss of appetite, and anxiety, in patients with lung cancer undergoing chemotherapy.
A quasi-experimental study was conducted using historical controls to assess and compare the effect of a novel symptom cluster management intervention on the severity of fatigue, loss of appetite, and anxiety in patients with lung cancer undergoing chemotherapy. Lung cancer patients were recruited from an outpatient chemotherapy unit at a university hospital in Thailand. Eighty participants were assigned equally to the experimental and control groups. The study outcomes, including fatigue, loss of appetite, and anxiety, were assessed with the Edmonton Symptom Assessment System at baseline and days 7, 14, and 28 postintervention. Repeated-measures ANOVA was analyzed to determine mean differences between groups across time.
Overall, anxiety decreased gradually on days 7, 14, and 28 ( < 0.001 for all time points) in the experimental group. Fatigue and loss of appetite also declined after days 14 ( < 0.001) and 28 ( < 0.001) compared to baseline. The significant effects of the interaction terms time × group ( < 0.001) for all symptoms within the cluster indicate the benefit of the intervention over time.
The pattern of changes in the symptom cluster across the study period was significantly different between the two study groups. Patients in the experimental group reported an improvement in fatigue, loss of appetite, and anxiety over time after receiving the intervention. The results suggested that the symptom cluster management intervention provided a promising approach for the simultaneous treatment of multiple symptoms within a cluster.
肺癌患者会经历各种令人痛苦的症状。本研究旨在基于症状管理理论采用症状群管理干预措施,以减轻接受化疗的肺癌患者症状群(包括疲劳、食欲不振和焦虑)的严重程度。
采用历史对照进行一项准实验研究,以评估和比较一种新型症状群管理干预措施对接受化疗的肺癌患者疲劳、食欲不振和焦虑严重程度的影响。肺癌患者从泰国一所大学医院的门诊化疗科招募。80名参与者被平均分配到实验组和对照组。在基线以及干预后第7天、14天和28天,使用埃德蒙顿症状评估系统评估包括疲劳、食欲不振和焦虑在内的研究结果。采用重复测量方差分析来确定不同时间组间的平均差异。
总体而言,实验组在第7天、14天和28天焦虑逐渐减轻(所有时间点P<0.001)。与基线相比,疲劳和食欲不振在第14天(P<0.001)和28天(P<0.001)后也有所下降。症状群内所有症状的交互项时间×组的显著效应(P<0.001)表明随着时间推移干预有益。
两个研究组在研究期间症状群的变化模式有显著差异。实验组患者在接受干预后,随着时间推移疲劳、食欲不振和焦虑有所改善。结果表明症状群管理干预为同时治疗症状群内的多种症状提供了一种有前景的方法。